Browsing: Spotlight Resources

Mercodia Lispro-Validation
0

Insulin lispro is a rapid-acting insulin analog that was first introduced in 1996 to treat people with diabetes. For an LBA (ligand binding assay) to qualify as a PK assay, several requirements for assay design, as well as analytical performance, are specified in industry guidelines. For insulin lispro, an easy-to-use, high quality PK assay that can meet the pharmaceutical industry requirements for multiple phases of drug development is needed

Feature image
0

As part of our mini-Spotlight on cell and gene therapies, we carried out a survey to gain an insight into the trends, challenges and developments associated with these fields – find out the results in this informative infographic.

Proteomics infographic feature image
0

As part of our mini-Spotlight on proteomics, we carried out a survey to gain an insight into the trends, challenges and developments associated with proteomics R&D – find out the results in this informative infographic.

1 2 3 4 5 18